British Journal of Cancer - Table of Contents alert Volume 106 Issue 3

TABLE OF CONTENTS Volume 106, Issue 3 (429-616) Published online 31 January 2012 In this issue Minireview Clinical Studies Translational Therapeutics Molecular Diagnostics Epidemiology Also new today Advance online publication Advertisement 13th Milan Breast Cancer Conference We look forward to meeting you in Milan (Italy) from 22nd to 24th June 2011. For more information please visit the website www.breastmilan.com Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement British Journal of Cancer publishes high quality original papers and reviews that make a significant contribution to increasing understanding of the causes of cancer and to improving the treatment and survival of patients. Visit the journal online at www.bjcancer.com to view the latest research and access selected articles FREE of charge.   Minireview Top The DNA damage response in viral-induced cellular transformation P A Nikitin and M A Luftig Br J Cancer 2012 106: 429-435; advance online publication, January 12, 2012; 10.1038/bjc.2011.612 Abstract | Full Text Clinical Studies Top Risk profiles of prostate cancers identified from UK primary care using national referral guidelines H Serag, S Banerjee, K Saeb-Parsy, S Irving, K Wright, S Stearn, A Doble and V J Gnanapragasam Br J Cancer 2012 106: 436-439; advance online publication, January 12, 2012; 10.1038/bjc.2011.596 Abstract | Full Text Brain metastases free survival differs between breast cancer subtypes A Berghoff, Z Bago-Horvath, C De Vries, P Dubsky, U Pluschnig, M Rudas, A Rottenfusser, M Knauer, H Eiter, F Fitzal, K Dieckmann, R M Mader, M Gnant, C C Zielinski, G G Steger, M Preusser and R Bartsch Br J Cancer 2012 106: 440-446; advance online publication, January 10, 2012; 10.1038/bjc.2011.597 Abstract | Full Text Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection G M Clifford, M Lise, S Franceschi, M Egger, C Bouchardy, D Korol, F Levi, S Ess, G Jundt, G Wandeler, J Fehr, P Schmid, M Battegay, E Bernasconi, M Cavassini, A Calmy, O Keiser, F Schöni-Affolter and the Swiss HIV Cohort Study Br J Cancer 2012 106: 447-452; advance online publication, January 12, 2012; 10.1038/bjc.2011.558 Abstract | Full Text Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC) J Souglakos, N Ziras, S Kakolyris, I Boukovinas, N Kentepozidis, P Makrantonakis, S Xynogalos, Ch Christophyllakis, Ch Kouroussis, L Vamvakas, V Georgoulias and A Polyzos Br J Cancer 2012 106: 453-459; advance online publication, January 12, 2012; 10.1038/bjc.2011.594 Abstract | Full Text Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study B Royer, E Kalbacher, S Onteniente, V Jullien, D Montange, S Piedoux, A Thiery-Vuillemin, D Delroeux, S Pili-Floury, E Guardiola, M Combe, P Muret, V Nerich, B Heyd, B Chauffert, J-P Kantelip and X Pivot Br J Cancer 2012 106: 460-467; advance online publication, December 15, 2011; 10.1038/bjc.2011.557 Abstract | Full Text Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours E Dean, M R Middleton, T Pwint, H Swaisland, J Carmichael, P Goodege-Kunwar and M Ranson Br J Cancer 2012 106: 468-474; advance online publication, January 5, 2012; 10.1038/bjc.2011.555 Abstract | Full Text Translational Therapeutics Top BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML W-H Lin, W-T Jiaang, C-W Chen, K-J Yen, S-Y Hsieh, S-C Yen, C-P Chen, K-Y Chang, C-Y Chang, T-Y Chang, Y-L Huang, T-K Yeh, Y-S Chao, C-T Chen and J T-A Hsu Br J Cancer 2012 106: 475-481; advance online publication, December 20, 2011; 10.1038/bjc.2011.564 Abstract | Full Text The cyclin-dependent kinase inhibitor p57Kip2 is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer H M Coley, N A M Safuwan, P Chivers, E Papacharalbous, T Giannopoulos, S Butler-Manuel, K Madhuri, D P Lovell and T Crook Br J Cancer 2012 106: 482-489; advance online publication, January 10, 2012; 10.1038/bjc.2011.566 Abstract | Full Text Irreversible electroporation on the small intestine M A Phillips, R Narayan, T Padath and B Rubinsky Br J Cancer 2012 106: 490-495; advance online publication, January 5, 2012; 10.1038/bjc.2011.582 Abstract | Full Text Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer G R Simpson, A Horvath, N E Annels, T Pencavel, S Metcalf, R Seth, P Peschard, T Price, R S Coffin, H Mostafid, A A Melcher, K J Harrington and H S Pandha Br J Cancer 2012 106: 496-507; advance online publication, January 12, 2012; 10.1038/bjc.2011.577 Abstract | Full Text Molecular Diagnostics Top A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker L Khoja, A Backen, R Sloane, L Menasce, D Ryder, M Krebs, R Board, G Clack, A Hughes, F Blackhall, J W Valle and C Dive Br J Cancer 2012 106: 508-516; advance online publication, December 20, 2011; 10.1038/bjc.2011.545 Abstract | Full Text Potential role of a navigator gene NAV3 in colorectal cancer E Carlsson, A Ranki, L Sipilä, L Karenko, W M Abdel-Rahman, K Ovaska, L Siggberg, U Aapola, R Ässämäki, V Häyry, K Niiranen, M Helle, S Knuutila, S Hautaniemi, P Peltomäki and K Krohn Br J Cancer 2012 106: 517-524; advance online publication, December 15, 2011; 10.1038/bjc.2011.553 Abstract | Full Text Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional consequence of mammary mineralisation R F Cox, A Hernandez-Santana, S Ramdass, G McMahon, J H Harmey and M P Morgan Br J Cancer 2012 106: 525-537; advance online publication, January 10, 2012; 10.1038/bjc.2011.583 Abstract | Full Text Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material L A M Gravendeel, J J de Rooi, P H C Eilers, M J van den Bent, P A E Sillevis Smitt and P J French Br J Cancer 2012 106: 538-545; advance online publication, December 20, 2011; 10.1038/bjc.2011.547 Abstract | Full Text The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma K Giannopoulos, W Kaminska, I Hus and A Dmoszynska Br J Cancer 2012 106: 546-552; advance online publication, January 5, 2012; 10.1038/bjc.2011.575 Abstract | Full Text Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors Y Xu, T Brenn, E R S Brown, V Doherty and D W Melton Br J Cancer 2012 106: 553-561; advance online publication, January 5, 2012; 10.1038/bjc.2011.568 Abstract | Full Text ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours S Karger, K Krause, M Gutknecht, K Schierle, D Graf, F Steinert, H Dralle and D Führer Br J Cancer 2012 106: 562-568; advance online publication, January 5, 2012; 10.1038/bjc.2011.578 Abstract | Full Text Epidemiology Top Standard errors of non-standardised and age-standardised relative survival of cancer patients L Jansen, T Hakulinen and H Brenner Br J Cancer 2012 106: 569-574; advance online publication, December 15, 2011; 10.1038/bjc.2011.560 Abstract | Full Text Estimating the asbestos-related lung cancer burden from mesothelioma mortality V McCormack, J Peto, G Byrnes, K Straif and P Boffetta Br J Cancer 2012 106: 575-584; advance online publication, January 10, 2012; 10.1038/bjc.2011.563 Abstract | Full Text Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study Y Gao, A Baccarelli, X O Shu, B-T Ji, K Yu, L Tarantini, G Yang, H-L Li, L Hou, N Rothman, W Zheng, Y-T Gao and W-H Chow Br J Cancer 2012 106: 585-591; advance online publication, December 15, 2011; 10.1038/bjc.2011.562 Abstract | Full Text Alcohol intake and mortality among women with invasive breast cancer H R Harris, L Bergkvist and A Wolk Br J Cancer 2012 106: 592-595; advance online publication, January 3, 2012; 10.1038/bjc.2011.561 Abstract | Full Text Dietary fat intake and risk of ovarian cancer in the NIH-AARP Diet and Health Study M M Blank, N Wentzensen, M A Murphy, A Hollenbeck and Y Park Br J Cancer 2012 106: 596-602; advance online publication, January 5, 2012; 10.1038/bjc.2011.572 Abstract | Full Text Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies S C Larsson and A Wolk Br J Cancer 2012 106: 603-607; advance online publication, January 12, 2012; 10.1038/bjc.2011.585 Abstract | Full Text Meat consumption and the risk of incident distal colon and rectal adenoma L M Ferrucci, R Sinha, W-Y Huang, S I Berndt, H A Katki, R E Schoen, R B Hayes and A J Cross Br J Cancer 2012 106: 608-616; advance online publication, December 13, 2011; 10.1038/bjc.2011.549 Abstract | Full Text Advertisement Ensure your access to British Journal of Cancer If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to this journal. Our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research. Recommend now at http://www.nature.com/librec/svc/request/makeCommRequest?id=2.   Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.